A matrix-biology story: one tripeptide, a copper ion, and the cell and rodent experiments that defined its literature.
In short
- Glycyl-L-histidyl-L-lysine (GHK) was isolated from human plasma by Pickart and Thaler in 1973, as a fraction that altered how cultured liver cells behaved.
- GHK binds copper(II) tightly, and almost all of the biological literature is on the copper complex, GHK-Cu, rather than the free peptide.
- In fibroblast cultures Maquart and colleagues reported increased collagen synthesis; in rat experimental wounds they reported increased connective-tissue accumulation. Those are findings in cells and in rodents.
- Pickart and Margolina's 2018 review queried a public gene-expression database and reported that exposure of cultured cells to GHK tracked shifts in the transcription of many genes — a screen, not an outcome in anyone.
A fraction in human serum
The compound was found while looking for something else. Pickart and Thaler, working with cultured liver cells, reported in Nature: New Biology in 1973 that a low-molecular-weight fraction of human serum changed how those cells behaved, and traced the activity to a tripeptide: glycyl-L-histidyl-L-lysine, three amino acids and nothing more. It was a description of an activity in a dish and the molecule behind it, not a claim about people.
Three residues is small even by peptide standards, and the sequence has an obvious chemical feature. The histidine imidazole, the terminal amine and the backbone together make a near-ideal pocket for a metal ion, and the ion that fits is copper. That observation is the reason the free peptide is rarely the thing actually studied.
Copper, and why the complex is the subject
GHK forms a stable coordination complex with copper(II), and it is that complex — written GHK-Cu — that most of the downstream work uses. This matters for reading the literature: a paper on "GHK" and a paper on "GHK-Cu" are not necessarily studying the same species, and the copper is not incidental packaging. Where investigators compared them, the metal was part of what they were measuring.
The practical consequence is that claims about the free peptide and claims about the complex should be kept apart. Several entries in the Regenerative world are copper-peptide blends; the catalog pages name the species they contain, and the matrikines article covers the separate question of collagen-derived fragments.
The fibroblast and wound experiments
The best-characterised line of work is on connective tissue. Maquart and colleagues reported in FEBS Letters in 1988 that GHK-Cu added to human fibroblast cultures increased collagen synthesis in those cultures. In the Journal of Clinical Investigation in 1993 the same group reported that GHK-Cu applied to experimental wounds in rats was associated with greater accumulation of connective tissue in the wound bed.
Later work looked at the enzymes that remodel matrix rather than only at its deposition. Siméon and colleagues reported in Life Sciences in 2000 that GHK-Cu increased the expression of matrix metalloproteinase-2 in fibroblast cultures — an observation about a specific enzyme in a specific cell type, which complicates any simple "builds tissue" reading, because the same complex was associated with both synthesis and degradation machinery depending on what was measured.
None of these is a study in a person. Two are cell culture; one is a rodent wound model. They establish that the copper complex is biologically active in those systems and point to collagen and matrix turnover as where the activity shows up.
The gene-expression screens
A second, more recent strand is transcriptional. Pickart reviewed the tissue-remodeling literature in the Journal of Biomaterials Science in 2008, and Pickart, Vasquez-Soltero and Margolina argued in BioMed Research International in 2015 that GHK engages a wide set of cellular pathways rather than a single target.
The 2018 review by Pickart and Margolina in the International Journal of Molecular Sciences is the clearest example of the method and its limits. The authors queried a public gene-expression resource and reported that exposure of cultured cells to GHK was associated with up- or down-shifts in the transcription of a large number of genes. That is a hypothesis-generating screen: it says which transcripts moved in culture, not what happens in a tissue, an animal or a person.
Read that way, the gene data are a map of where to look, not a result. The honest summary of the whole body of work is that GHK-Cu is active in cells and in rodent wounds in assays of collagen and matrix turnover, and that a broad transcriptional footprint has been reported in vitro.
The limits
GHK-Cu is not an approved drug. The literature summarised here is in cells, in rodent wounds, and in transcriptional screens, and a cosmetic-ingredient history is not the same thing as controlled human trials. Nothing above describes an effect in a person, and none of it is a protocol or any guidance on use.
The compound and blend pages in the Regenerative world name the copper-peptide species they contain and the models the work was done in, and the matrikines article covers the adjacent collagen-fragment literature.
References
- Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature: New Biology. 1973;243(124):85–87.
- Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. 1988;238(2):343–346.
- Maquart FX, Bellon G, Chaqour B, et al.. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. Journal of Clinical Investigation. 1993;92(5):2368–2376.
- Siméon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sciences. 2000;67(18):2257–2265.
- Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. 2008;19(8):969–988.
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108.
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987.
What this article is, and is not
This is a summary of published research, written for qualified professionals evaluating compounds for laboratory work. Every compound discussed is supplied by strictly for in-vitro and laboratory research use. None is a drug, a dietary supplement, or a cosmetic; none is intended for human or veterinary use; and nothing above is medical advice, a treatment recommendation, or a claim that any compound produces any effect in a person. We publish no dosing or administration guidance of any kind.
